Sofinnova Ventures

Contact: Jim Healy, General Partner    Email this Investor

• Biotechnology
• Medical equipment
• Networking

• Seed
• 1st Round
• 2nd Round
• 3rd Round
• 4th Round and later
• Pre-IPO
• Mezzanine
• Buyout/acquisition

• Private Company (backed by venture capital firms)
• Private Company (not backed by venture capital firms)
• Public Company

Sofinnova SA launched U.S. investment funds in 1974, making it the first European venture company to enter the U.S. market. Based in San Francisco, with Jean Deleage as its first President and founder, Sofinnova SA was very successful and an early investor in stellar successes such as Tandem Computers and Genentech. In 1984, Sofinnova SA decided to leverage its unique trans-Atlantic positioning by creating a direct partnership presence in the U.S., creating our current generation of funds independent from the Paris team.

Email this Investor